Neuron23

AI-based drug discovery model for researchers

placeSan Francisco, California, United States calendar_todayFounded 2018 groups29 employees language neuron23.com

Registered entities

Innovation

14 patent families — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 82 times.

YearFilings
20224
20235
20249
20259
20262

Social engagement

Social engagement: 6.5K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include SoftBank Vision Fund, Westlake Village Biopartners, Kleiner Perkins, Redmile Group.

Investor typeCountShare
Venture capital655%
Private equity19%
Bank & private debt19%
Other / undisclosed327%

Recent activity

29 May 2026
Partnership
Paradon's Foundation
Coming soon